Trial Site Detail

 

Drug:
CB-839
Trial:
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors
Conditions: Solid Tumors
Trial Status:
Active, not recruiting

 

Naytional Cancer Institute

Building 10, Room 1-3750     10 Center Drive
Bethesda , MD 20814
USA

 

Principal Investigator:
Ramaprasad Srinivasan, MD
Contact:
Geri Hawks, RN 301-402-7913 ghawks@mail.nih.gov Contact: Ramaprasad Srinivasan, MD 301-451-2298 ramasrin@mail.nih.gov
Activation Status of this Site:
Closed
Notes about this Site:
Naytional Cancer Institute Website:
http://www.cc.nih.gov/index.html

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.